| Date Filed | Type | Description |
| 06/16/2023 |
4
| Froimson Mark (Director) has filed a Form 4 on Pacira BioSciences, Inc.|
Txns:
| Granted 1,775 shares
@ $0
Granted 12,925 options to buy
@ $38.74, valued at
$500.7k
|
|
| 06/08/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/11/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/20/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/11/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/17/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/11/2020 |
4
| Froimson Mark (Director) has filed a Form 4 on Pacira BioSciences, Inc.|
Txns:
| Granted 1,260 shares
@ $0
Granted 8,027 options to buy
@ $47.65, valued at
$382.5k
|
|
| 12/19/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/06/2019 |
4
| Froimson Mark (Director) has filed a Form 4 on Pacira BioSciences, Inc.|
Txns:
| Granted 4,134 shares
@ $0
Granted 8,437 options to buy
@ $43.54, valued at
$367.3k
|
|
| 06/15/2018 |
4
| Froimson Mark (Director) has filed a Form 4 on Pacira Pharmaceuticals, Inc.|
Txns:
| Granted 782 shares
@ $0
Granted 4,693 options to buy
@ $38.35, valued at
$180k
|
|
| 08/16/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/16/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 06/16/2017 |
3
| Froimson Mark (Director) has filed a Form 3 on Pacira Pharmaceuticals, Inc. |